Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlencowe Resources Regulatory News (BRES)

Share Price Information for Blencowe Resources (BRES)

Share Price is delayed by 15 minutes
Get Live Data
8.10    0.06 (0.75%)
Bid:
7.90
Ask:
8.30
Spread: 0.40 (5.063%)
Market Cap: £39.85m
BRES Live PriceLast checked at - London Stock Exchange

Intraday Blencowe Resources Share Chart

Testwork Confirms Highest Purity

15 Jan 2026 07:14

RNS Number : 0355P
Blencowe Resources PLC
15 January 2026
 

Date: 15 January 2026

 

Blencowe Resources Plc

("Blencowe" or the "Company"),

 

European Purification Testwork Confirms Highest Purity Graphite Products

Results Strengthen Strategic Value of Orom-Cross for High-Value Defence and Energy Markets

 

 

Blencowe Resources Plc (LSE: BRES) is pleased to announce further exceptional high-grade purification results from testwork undertaken in association with Alkeemia S.P.A.("Alkeemia"), a specialist graphite processing organisation based in Porto Marghera, Northern Italy. This is the first Orom-Cross purification test work conducted within the EU and it represents a bridge into that significant market moving forward.

 

Highlights

· Purification testing upgraded all Orom-Cross products to 99.99 carbon content. It is extremely rare for purified graphite to achieve these 4-nines.

· Four-nines purity is considered the highest purification grade possible and is required for lucrative defence, nuclear and specialist energy applications.

· Independent European processing confirms non-Chinese purification capability.

· Alkeemia's process offers a cleaner, lower-toxicity and lower-carbon alternative to conventional Chinese technologies.

· Independent testing by a specialist European firm strengthens ongoing offtake discussions and opens additional sales opportunities into European markets.

· Discussions with Alkeemia regarding potential direct offtake and European purification arrangements.

 

Strategic Significance

Initial results show that all Orom-Cross concentrates tested were successfully upgraded using Alkeemia's proprietary process to achieve 99.99% carbon content, exceeding the 99.95% purity typically required for lithium-ion battery applications.

This level of purity enables Blencowe to target higher-value, strategically important end markets including niche defence and nuclear and specialist industrial applications where product quality, traceability and supply security are critical.

Importantly, the Alkeemia process provides a Western, non-Chinese, purification route, utilising a simpler, less toxic, and more cost-effective methodology than conventional acid-based processes widely used in China. This further aligns Orom-Cross with growing European and US policy objectives to establish secure independent, and sustainable critical mineral supply chains.

Orom-Cross has previously achieved 99.99% purity through testwork conducted by American Energy Technology ("AETC"), a US based technical graphite specialist, using their own proprietary thermal process that differs from the chemical-based approach employed by Alkeemia. The AETC relationship has since evolved to introduce Blencowe a range of valuable niche offtake opportunities, including testing with US Dept of Defence and the EU SAFELOOP initiative. 

Blencowe believes that engagement with Alkeemia has the potential to develop in a similar manner providing a gateway to European downstream markets. With AETC and Alkeemia utilising different purification methodologies, the Company is also broadening its downstream optionality across multiple high-purity processing routes.

 

Figure 1: Purification testing on Orom-Cross products.

 

Future Relationship

Blencowe and Alkeemia have identified areas of mutual technical and commercial interest and are continuing discussions regarding potential future collaboration.

The ability to deliver ultra-high-purity graphite products through a European-based purification route adds further upside potential to the DFS economics by expanding access to higher-margin, supply-constrained end markets. Engagement with specialist European processors such as Alkeemia also provides valuable technical validation and supports broader dialogue with a wider range of downstream customers and strategic end users, particularly within Europe.

 

Cameron Pearce, Blencowe's Executive Chairman commented:

"These purification results are a significant milestone for Orom-Cross and once again demonstrate that our graphite can achieve the very highest purity levels required for specialist applications, including defence, nuclear and strategic energy uses where quality and supply security are critical. It also opens the potential for a valuable new partnership to develop.

Achieving 99.99% carbon content through a non-Chinese, European-based purification route materially enhances the strategic value of Orom-Cross. It positions the project not only as a large-scale, low-cost graphite development, but also as a credible contributor to Western critical mineral supply chains.

Importantly, this work adds further upside potential to the economics outlined in our DFS by broadening access to higher-margin, supply-constrained markets. Combined with the scale we continue to demonstrate through drilling, this reinforces Orom-Cross as a long-life, strategically relevant asset as we advance funding and offtake discussions."

 

**ENDS**

 

For further information please contact:

 

Blencowe Resources Plc

www.blencoweresourcesplc.com

 

Sam Quinn (Director)

Tel: +44 (0)1624 681 250

info@blencoweresourcesplc.com

 

Sasha Sethi (Investor Relations)

Tel: +44 (0) 7891 677 441

sasha.sethi@blencoweresourcesplc.com

Tavira Financial (Joint Broker)

 

Jonathan Evans

 

 

Tel: +44 (0)20 3192 1733

jonathan.evans@tavira.group

Oak Securities (Joint Broker)

 

Calvin Man /Mungo Sheehan / Jerry Keen

 

 

Tel: +44 (0)20 3973 3678

Twitter

https://twitter.com/BlencoweRes

LinkedIn

https://www.linkedin.com/company/72382491/admin/

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVONRNNUAARR
Date   Source Headline
4th Jun 20267:01 amRNS-ROak Securities Research Note Following DFS Update
2nd Jun 202610:45 amRNSExercise of Share Options
29th May 20267:00 amRNSOrom Cross Graphite DFS NPV10 up 15% to US$1.254bn
28th May 20267:04 amRNS-RAppointment of Joint Broker
26th May 202612:46 pmRNSHalf-year Financial Report
18th May 20267:00 amRNSBeehive Deposit Maiden JORC Resource
7th May 20267:36 amRNSRocket Component Testing Programme
30th Apr 20267:00 amRNSBeehive Final Assay Results
16th Apr 20267:00 amRNSBeehive Drilling Results
17th Mar 20267:00 amRNSBeehive Drilling Returns Multiple 30m Intercepts
17th Mar 20267:00 amRNSBeehive Drilling Returns Multiple 30m Intercepts
13th Mar 202612:57 pmRNSEXERCISE OF SHARE OPTIONS
6th Mar 20267:00 amRNSMaiden 16.9 Mt JORC Resource for Iyan Deposit
26th Feb 20262:57 pmRNSResult of AGM
24th Feb 20267:00 amRNSFinal Ilyan Drilling Results
20th Feb 202611:03 amRNSLong Term Incentive Programme
16th Feb 20267:00 amRNSUS AD/CVD Ruling Supports Non-China Supply
10th Feb 20267:00 amRNSHigh Value Synthetic Diamond Manufacture
6th Feb 20267:00 amRNSIyan - Further Significant Graphite Intercepts
2nd Feb 20267:00 amRNSIyan Deposit Delivers Multiple Intercepts over 30M
30th Jan 202611:29 amRNSAnnual Financial Report
23rd Jan 20267:57 amRNSEuropean Processing & Offtake with Alkeemia
15th Jan 20267:14 amRNSTestwork Confirms Highest Purity
13th Jan 202610:50 amRNSBlock Listing Application
13th Jan 20267:00 amRNS-RBroker Research Initiation
9th Jan 20267:00 amRNSBeehive Delivers 2 Standout +90 metre Intercepts
7th Jan 20269:17 amRNSDFS Performance Shares - Replacement
7th Jan 20268:25 amRNSExercise of Warrants
5th Jan 20264:14 pmRNSExercise of Warrants
30th Dec 202510:54 amRNSIssue of DFS Performance Shares
30th Dec 202510:54 amRNSIssue of DFS Performance Shares
23rd Dec 20257:00 amRNSBeehive Returns 92.55m @ 6.83% TGC from Surface
18th Dec 20257:00 amRNSFurther Strong Deep-Hole Results at Iyan
16th Dec 202511:47 amRNSExercise of Warrants
12th Dec 20257:00 amRNSExceptional Iyan Deep Hole Highlights Scale
11th Dec 20257:00 amRNSFundraise of £3m
9th Dec 20257:01 amRNSOfftake MOU with Yunasko Ltd.
9th Dec 20257:00 amRNSExercise of Warrants
8th Dec 20253:46 pmRNSExercise of Warrants
2nd Dec 20257:00 amRNSExercise of Share Options
1st Dec 20258:58 amRNS-RPresentation & Interview
1st Dec 20257:00 amRNSDFS Results Confirms Outstanding Economics
27th Nov 20257:00 amRNSJORC Resource Upgrade
25th Nov 202510:30 amRNSPublication of a Prospectus
17th Nov 20257:00 amRNSExercise of Warrants
13th Nov 202512:08 pmRNSExercise of Warrants
13th Nov 20258:30 amRNS-RResourcing Tomorrow Conference
12th Nov 202510:47 amRNSHolding(s) in Company
7th Nov 20258:00 amRNS-RCEO Interview
31st Oct 20257:08 amRNSNorthern Syncline Drilling Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.